4.4 Article

Plantazolicin, a Novel Microcin B17/Streptolysin S-Like Natural Product from Bacillus amyloliquefaciens FZB42

Journal

JOURNAL OF BACTERIOLOGY
Volume 193, Issue 1, Pages 215-224

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JB.00784-10

Keywords

-

Categories

Funding

  1. Competence network Genome Research on Bacteria (GenoMikPlus)
  2. German Ministry for Education and Research [0330798A]
  3. NIH/NCI [T32 CA009523]
  4. University of Illinois
  5. NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097142] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Here we report on a novel thiazole/oxazole-modified microcin (TOMM) from Bacillus amyloliquefaciens FZB42, a Gram-positive soil bacterium. This organism is well known for stimulating plant growth and biosynthesizing complex small molecules that suppress the growth of bacterial and fungal plant pathogens. Like microcin B17 and streptolysin S, the TOMM from B. amyloliquefaciens FZB42 undergoes extensive posttranslational modification to become a bioactive natural product. Our data show that the modified peptide bears a molecular mass of 1,335 Da and displays antibacterial activity toward closely related Gram-positive bacteria. A cluster of 12 genes that covers similar to 10 kb is essential for the production, modification, export, and self-immunity of this natural product. We have named this compound plantazolicin (PZN), based on the association of several producing organisms with plants and the incorporation of azole heterocycles, which derive from Cys, Ser, and Thr residues of the precursor peptide.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available